menu search

Illumina ordered to pay chinese company $333 million in gene-sequencing patent case

A Delaware jury on Friday ordered Illumina Inc to pay more than $333 million to a U.S. unit of Chinese geneti<...

May 6, 2022, 4:46 pm

Myriad genetics, inc. (mygn) ceo paul diaz on q1 2022 results - earnings call transcript

Myriad Genetics, Inc. (NASDAQ:MYGN ) Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET Company Pa...

May 5, 2022, 11:05 pm

Vertex pharmaceuticals incorporated (vrtx) ceo dr. reshma kewalramani on q1 2022 results - earnings call transcript

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX ) Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET Company Participants Michael Partridge - SV...

May 5, 2022, 9:05 pm

Fulgent genetics, inc. (flgt) ceo ming hsieh on q1 2022 results - earnings call transcript

Fulgent Genetics, Inc. (NASDAQ:FLGT ) Q1 2022 Earnings Conference Call May 3, 2022 4:30 PM ET Company P...

May 3, 2022, 7:58 pm

Fulgent genetics, inc. (flgt) surpasses q1 earnings and revenue estimates

Fulgent Genetics, Inc. (FLGT) delivered earnings and revenue surprises of 14.12% and 6.58%, respectivel...

May 3, 2022, 6:49 pm

Adaptive biotechnologies to present at the bofa securities 2022 healthcare conference

SEATTLE, May 02, 2022 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage bio...

May 2, 2022, 4:05 pm

eneti inc. to announce first quarter 2022 results and have a conference call on may 12, 2022

MONACO, April 25, 2022 (GLOBE NEWSWIRE) -- eneti Inc. (NYSE: NETI) (the “Company”) plans to announc...

April 25, 2022, 4:12 pm

Genetic technologies limited (gene) ceo simon morriss on q3 2022 results - earnings call transcript

Genetic Technologies Limited (NASDAQ:GENE ) Q3 2022 Earnings Conference Call April 20, 2022 6:00 PM ET ...

April 20, 2022, 10:54 pm

Fulgent genetics to announce first quarter 2022 financial results on tuesday, may 3, 2022

TEMPLE CITY, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent G...

April 18, 2022, 4:03 pm

Verve therapeutics: early-stage biotech with a large market

Verve Therapeutics is a biotechnology company with a vision to provide cutting-edge solutions to cardiovascular diseases. The company is dedicated to ...

April 16, 2022, 12:31 am

Morgan stanley tops profit estimates in tough earnings season for banks

Like all banks, Morgan Stanley is contending with a decline in profits from last year as the frenetic t...

April 14, 2022, 8:07 am

Fulgent genetics: now the going could get much tougher

Fulgent Genetics: Now The Going Could Get Much Tougher...

April 10, 2022, 6:34 am

Rhythm pharmaceuticals (rytm) down due to study design changes

Rhythm Pharmaceuticals (RYTM) modifies the design of its two genetic obesity disorder studies to focus ...

April 7, 2022, 3:48 pm

Burcon nutrascience receives co-investment from proteins industries canada to develop food-grade proteins from sunflower seeds

Burcon NutraScience Corporation announced that it has received a co-investment from Proteins Industries Canada for the development of high-quality pro...

April 7, 2022, 11:09 am

Sqz biotechnologies to present at upcoming investor conferences

WATERTOWN, Mass.--(BUSINESS WIRE)--SQZ Biotechnologies (NYSE: SQZ), focused on unlocking the full potential of cell therapies for multiple therapeutic...

April 6, 2022, 4:45 pm

Rhythm pharma shares fall after modifications to setmelanotide trials in rare diseases of obesity

Rhythm Pharmaceuticals Inc (NASDAQ: RYTM) will modify its Phase 3 EMANATE and ongoing Phase 2 DAYBREAK trials of setmelanotide in rare g...

April 6, 2022, 12:03 pm

Mustang bio to present at the virtual fortress biotech r&d summit hosted by b. riley securities

WORCESTER, Mass., April 04, 2022 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focu...

April 4, 2022, 8:00 am

Proqr to present axiomer rna editing platform technology at rna editing summit

LEIDEN, Netherlands & CAMBRIDGE, Mass., April 04, 2022 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedic...

April 4, 2022, 7:00 am


Search within

Pages Search Results: